Lambo, Rogelio T.

HRN: 10-66-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/16/2025
11/23/2025
IV
2.25g
Q6
PMBO
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominalUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: No  Wrong Dose 

Final appropriateness: No  Wrong Dose 

Overall appropriateness: No  Adjust Dose According To EGFR

Intervention



Type of Intervention done:

                    

           


Acceptance: